Shopping Cart
Remove All
Your shopping cart is currently empty
Syk-IN-4 is a potent, selective, and orally bioavailable inhibitor of SYK, with an IC50 of 0.31 nM, targeting SYK, a potential therapeutic target for autoimmunity and hematological cancers[1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $373 | Inquiry | Inquiry | |
| 10 mg | $663 | Inquiry | Inquiry | |
| 25 mg | $1,320 | Inquiry | Inquiry | |
| 50 mg | $2,150 | Inquiry | Inquiry | |
| 100 mg | $3,230 | Inquiry | Inquiry | |
| 1 mL x 10 mM (in DMSO) | $397 | Inquiry | Inquiry |
| Description | Syk-IN-4 is a potent, selective, and orally bioavailable inhibitor of SYK, with an IC50 of 0.31 nM, targeting SYK, a potential therapeutic target for autoimmunity and hematological cancers[1]. |
| In vitro | Syk-IN-4 is a potent inhibitor of hERG with an IC50 of 3.0 μM[1], and it inhibits SUDHL-4 and T cell proliferation with GI50s of 0.24 μM and 2.6 μM, respectively[1]. |
| In vivo | Syk-IN-4 demonstrates moderate oral bioavailability (60%) when administered orally (1 mg/kg) in male Hans Wistar rats[1], while showing high plasma clearance (151 mL/min/kg) and large volume of distribution (1.0 L/kg respectively) upon intravenous administration (0.5 mg/kg) in the same animal model[1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: 62.5 mg/mL, Sonication is recommended. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.